Related Articles

• Proteomics analysis of potential serum biomarkers for insulin resistance in patients with polycystic ovary syndrome
• Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy (Review)
• Association of PPARG Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome
• Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study
• Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease